Treatment challenges associated with comorbid substance use and posttraumatic stress disorder: clinicians' perspectives
- PMID: 19219661
- PMCID: PMC2845168
- DOI: 10.1080/10550490802545141
Treatment challenges associated with comorbid substance use and posttraumatic stress disorder: clinicians' perspectives
Abstract
A significant proportion of individuals with substance use disorders (SUDs) meet criteria for comorbid posttraumatic stress disorder (PTSD). This comorbidity confers a more complicated clinical presentation that carries with it formidable treatment challenges for practitioners. The current study examined sources of difficulty and gratification among clinicians (N = 423) from four national organizations who completed an anonymous questionnaire. As expected, the findings revealed that comorbid SUD/PTSD was rated as significantly more difficult to treat than either disorder alone. The most common challenges associated with treating SUD/PTSD patients included knowing how to best prioritize and integrate treatment components, patient self-destructiveness and severe symptomatology, and helping patients abstain from substance use. The findings increase understanding of SUD/PTSD treatment challenges, and may be useful for enhancing therapist training programs, supervision effectiveness, and designing optimal SUD/PTSD interventions.
Similar articles
-
Concurrent Treatment of Substance Use and PTSD.Curr Psychiatry Rep. 2016 Aug;18(8):70. doi: 10.1007/s11920-016-0709-y. Curr Psychiatry Rep. 2016. PMID: 27278509 Free PMC article. Review.
-
Implementation of integrated therapies for comorbid post-traumatic stress disorder and substance use disorders in community substance abuse treatment programs.Drug Alcohol Rev. 2015 May;34(3):234-41. doi: 10.1111/dar.12229. Epub 2015 Mar 4. Drug Alcohol Rev. 2015. PMID: 25737377 Free PMC article. Review.
-
Clinicians' views on treating posttraumatic stress disorder and substance use disorder.J Subst Abuse Treat. 2002 Mar;22(2):79-85. doi: 10.1016/s0740-5472(02)00219-2. J Subst Abuse Treat. 2002. PMID: 11932133
-
Improving PTSD/substance abuse treatment in the VA: a survey of providers.Am J Addict. 2010 May-Jun;19(3):257-63. doi: 10.1111/j.1521-0391.2010.00039.x. Am J Addict. 2010. PMID: 20525033
-
Mental Health Clinician Practices and Perspectives on Treating Adults with Co-Occurring Posttraumatic Stress and Substance Use Disorders.J Dual Diagn. 2023 Oct-Dec;19(4):189-198. doi: 10.1080/15504263.2023.2260338. Epub 2023 Nov 1. J Dual Diagn. 2023. PMID: 37796916
Cited by
-
Concurrent Treatment of Substance Use and PTSD.Curr Psychiatry Rep. 2016 Aug;18(8):70. doi: 10.1007/s11920-016-0709-y. Curr Psychiatry Rep. 2016. PMID: 27278509 Free PMC article. Review.
-
Pre-trauma insomnia and posttraumatic alcohol and cannabis use in the AURORA observational cohort study of trauma survivors.J Psychiatr Res. 2025 Jun 20;189:415-423. doi: 10.1016/j.jpsychires.2025.06.027. Online ahead of print. J Psychiatr Res. 2025. PMID: 40582081
-
Implementation of integrated therapies for comorbid post-traumatic stress disorder and substance use disorders in community substance abuse treatment programs.Drug Alcohol Rev. 2015 May;34(3):234-41. doi: 10.1111/dar.12229. Epub 2015 Mar 4. Drug Alcohol Rev. 2015. PMID: 25737377 Free PMC article. Review.
-
Predictors of therapeutic alliance, treatment feedback, and clinical outcomes among African American women in treatment for co-occurring PTSD and SUD.J Subst Abuse Treat. 2022 Aug;139:108766. doi: 10.1016/j.jsat.2022.108766. Epub 2022 Mar 22. J Subst Abuse Treat. 2022. PMID: 35346534 Free PMC article. Clinical Trial.
-
Augmenting Treatment for Posttraumatic Stress Disorder and Co-Occurring Conditions with Oxytocin.Curr Treat Options Psychiatry. 2019 Jun;6(2):132-142. doi: 10.1007/s40501-019-00171-1. Epub 2019 Apr 29. Curr Treat Options Psychiatry. 2019. PMID: 31763133 Free PMC article.
References
-
- Grant BF, Harford TC. Comorbidity between DSM-IV alcohol use disorders and major depression: Results of a national survey. Drug Alcohol Depend. 1995;39:197–206. - PubMed
-
- Grant BF, Hasin DS, Stinson FS, et al. Prevalence, correlates, co-morbidity, and comparative disability of DSM-IV generalized anxiety disorder in the USA: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Med. 2005;35:1747–1759. - PubMed
-
- Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III—R psychiatric disorders in the United States: Results from the National Comorbidity Study. Arch Gen Psychiatry. 1994;51:8–19. - PubMed
-
- Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990;264:2511–2518. - PubMed
-
- Conway KP, Compton W, Stinson FS, Grant BF. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2006;67:247–257. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials